JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Evaluation of pressure ulcer development and risk factors in COVID-19 patients followed in the ICU
Aims: In this study it was aimed to evaluate the causes of pressure ulcer development in COVID-19 patients followed in the intensive care unit (ICU).
Methods: Demographic data, comorbidities, laboratory parameters, treatment modalities and mortality rates of the patients were reviewed retrospectively from hospital records. In addition, Acute Physiology and Chronic Health Assessment (APACHE II), Sequential Organ Failure Assessment (SOFA), and modified NUTRIC scores were calculated. Braden scale was used for pressure ulcer evaluation.
Results: Eighty COVID-19 patients were included in the study. Pressure ulcers (PU) were detected in 29 (36.25%) of the cases, and no pressure ulcer was detected in 51 (63.75%) cases. 54 (69.7%) of the patients were male, 26 (32.5%) were female, and the mean age was 69 (61-77). The cases were divided into two groups according to the development of pressure ulcers. The APACHE II score was 24 (17-29) in the PU group and 18 (12-23) in the non-PU group (p=0.01), the mNUTRIC score was 4 (3-5) in the PU group and 3 (2-4) in the non-PU group.) (p=0.023), the Braden scale calculated at admission to the ICU was 11(10-13) in the PU group and 14(12-15) (p<0.001) in the non-PU group. A Braden scale score of <13 was found to be 22 (75.9) in the PU group and 14 (27.5) in the non-PU group, and 36 (45) patients in total (p<0.001).
Conclusion: The Braden Scale can be used in COVID-19 patients, since they are first admitted to the ICU, both for scoring the wound and predicting the (making a) prognosis quickly.


1. WHO. Q&amp;A on coronaviruses (COVID-19). Accessed july6, 2020. https://who.int/news-room/q-a-detail/q-a-coronaviruses
2. Sun P, Qie S, Liu Z, Ren J, Xi J. Clinical characteristics of 50466patients with 2019-nCoV infection. MedRxiv. 2020.
3. Montenegro F, Unigarro L, Paredes G, et al. Acute respiratorydistress syndrome (ARDS) caused by the novel coronavirusdisease (COVID-19): a practical comprehensive literature review.Exp Rev Respir Med. 2021;15(2):183-195.
4. Grasselli G, Greco M, Zanella A, et al. Risk Factors AssociatedWith Mortality Among Patients With COVID-19 inIntensive Care Units in Lombardy, Italy. JAMA Intern Med.2020;180(10):1345-1355. doi:10.1001/jamainternmed.2020.3539
5. WHO. Coronaviruses disease 2019 (COVID-19). 2019; https://www.who.int/emergencies/diseases/novel-coronavirus-2019
6. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Lopez-MedinaIM, Alvarez-Nieto C. Risk assessment scales for pressure ulcerprevention: a systematic review. J Adv Nurs. 2006;54(1):94-110.doi:10.1111/j.1365-2648.2006.03794.x
7. Beers MH, Berkow R. The Merck Manual of Geriatrics. Merck &amp;Co. Inc Whitehouse Station, NJ. 2000;
8. Kıraner E, H&uuml;lya K. COVID-19 Tanısı ile yoğun bakımdayatan hastalarda basın&ccedil; yaralanmalarının ve risk fakt&ouml;rlerininretrospektif analizi. Yoğun Bakım Hemşireliği Derg.2021;25(3):139-151.
9. Karahan A, AAbbasoğlu A, Işık SA, et al. Factors AffectingWound Healing in Individuals With Pressure Ulcers: ARetrospective Study. Ostomy/Wound Manage. 2018;64(2):32-39.
10. de Ara&uacute;jo TM, de Ara&uacute;jo MFM, Barros LM, de Oliveira FJG,da Silva LA, Caetano J&Aacute;. Educational intervention to assess theknowledge of intensive care nurses about pressure injury. RevRene. 2019;(20):42.
11. GENCER ZE, Erdin&ccedil; &Uuml;, &Ouml;ZKAN &Ouml;. Basın&ccedil; &uuml;lserleri tedavimaliyetleri etkililik analizi; konvansiyonel ve modern yarabakım tedavi maliyetlerinin karşılaştırılması. Akdeniz Tıp Derg.2019;5(2):201-208.
12. Tanrikulu F, Dikmen Y. Yoğun bakım hastalarında basın&ccedil; yaraları:risk fakt&ouml;rleri ve &ouml;nlemler. J Hum Rhythm. 2017;3(4):177-182.
13. Lovicu E, Faraone A, Fortini A. Admission braden scale scoreas an early independent predictor of in-hospital mortalityamong inpatients with COVID-19: a retrospective cohort study.Worldviews Evid Based Nurs. 2021;18(5):247-253.
14. Bandle B, Ward K, Min SJ, et al. Can Braden score predictoutcomes for hospitalized heart failure patients? J Am GeriatrSoc. 2017;65(6):1328-1332.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHEII: a severity of disease classification system. Crit Care Med.1985;13(10):818-829.
16. Vincent J-L, Moreno R, Takala J, et al. The SOFA (Sepsis-relatedOrgan Failure Assessment) score to describe organ dysfunction/failure. Springer-Verlag; 1996.
17. Zhang P, He Z, Yu G, et al. The modified NUTRIC score canbe used for nutritional risk assessment as well as prognosisprediction in critically ill COVID-19 patients. Clin Nutr.2021;40(2):534-541.
18. Defloor T, Schoonhoven L, Fletcher J, et al. Statement ofthe European Pressure Ulcer Advisory Panel--pressureulcer classification: differentiation between pressure ulcersand moisture lesions. J Wound Ostomy Continence Nurs.2005;32(5):302-306. doi:10.1097/00152192-200509000-00006
19. Cox J. Predictors of pressure ulcers in adult critical care patients.Am J Crit Care. 2011;20(5):364-375.
20. Bergstrom N, Demuth PJ, Braden B. A clinical trial of the BradenScale for predicting pressure sore risk. Nurs Clin North Am.1987;22(2):417-428.
21. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinicalnutrition in the intensive care unit. Clin Nutr. 2019;38(1):48-79.doi:10.1016/j.clnu.2018.08.037
22. Mechanick JI, Carbone S, Dickerson RN, et al. Clinical nutritionresearch and the COVID-19 pandemic: a scoping review of theASPEN COVID-19 task force on nutrition research. JPEN JParenter Enteral Nutr. 2021;45(1):13-31.
23. Reuler JB, Cooney TG. The pressure sore: pathophysiology andprinciples of management. Ann Intern Med. 1981;94(5):661-666.
24. Lyder CH. Pressure ulcer prevention and management. JAMA.2003;289(2):223-226.
25. Kurtuluş Z. Braden skalası ile belirlenen y&uuml;ksek riskli hastagrubunda alb&uuml;min d&uuml;zeyleri ile bası yaraları arasındaki ilişki.Marmara Universitesi (Turkey); 2003.
26. Armstrong R, Kane A, Kursumovic E, Oglesby F, Cook TM.Mortality in patients admitted to intensive care with COVID-19:an updated systematic review and meta-analysis of observationalstudies. Anaesthesia. 2021;76(4):537-548.
27. Cooper KL. Evidence-based prevention of pressure ulcers in theintensive care unit. Crit Care Nurse. 2013;33(6):57-66.
28. Coleman S, Nixon J, Keen J, et al. A new pressure ulcer conceptualframework. J Adv Nurs. 2014;70(10):2222-2234.
29. Haisley M, S&oslash;rensen J, Sollie M. Postoperative pressure injuriesin adults having surgery under general anaesthesia: systematicreview of perioperative risk factors. J Br Surg. 2020;107(4):338-347.
30. NPUAP. 2014; Available at: https://www.epuap.org/wp-content/uploads/2010/10/NPUAP-EPUAP-PPPIA-Quick-Reference-Guide-2014-DIGITAL.pdf
31. Berlowitz DR, Brandeis GH, Morris JN, et al. Deriving a risk-adjustment model for pressure ulcer development using theminimum data set. J Am Geriatr Soc. 2001;49(7):866-871.
32. Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19infection: a systematic review. Exp Rev Hematol. 2020;13(11):1265-1275.
33. Bluestein D, Javaheri A. Pressure ulcers: prevention, evaluation,and management. Am Fam Physician. 2008;78(10):1186-1194.
34. Borghardt AT, Prado TN, Bicudo SD, Castro DS, Bringuente ME.Pressure ulcers in critically ill patients: incidence and associatedfactors. &Uacute;lcera por press&atilde;o em pacientes cr&iacute;ticos: incid&ecirc;nciae fatores associados. Rev Bras Enferm. 2016;69(3):460-467.doi:10.1590/0034-7167.2016690307i
35. Alhazzani W, M&oslash;ller MH, Arabi YM, et al. Surviving SepsisCampaign: guidelines on the management of critically ill adultswith Coronavirus Disease 2019 (COVID-19). Intensive Care Med.2020;46(5):854-887. doi:10.1007/s00134-020-06022-5
Volume 4, Issue 4, 2023
Page : 288-295
_Footer